Literature DB >> 20015492

The association of uncarboxylated matrix Gla protein with mitral annular calcification differs by diabetes status: The Heart and Soul study.

Benjamin D Parker1, Leon J Schurgers, Cees Vermeer, Nelson B Schiller, Mary A Whooley, Joachim H Ix.   

Abstract

OBJECTIVE: Mitral annular calcification (MAC) and aortic stenosis (AS) are associated with systemic calcification and cardiovascular disease (CVD) events. Matrix Gla protein (MGP) is an inhibitor of vascular calcification and lower levels of its precursor - uncarboxylated MGP (ucMGP) - are associated with vascular calcification in pilot studies. METHODS AND
RESULTS: In this cross-sectional study of 839 outpatients with stable CVD, we measured serum ucMGP, and evaluated MAC and AS by echocardiography. The association of ucMGP with MAC differed by diabetes status (interaction P<0.001). Among participants without diabetes (n=615), higher ucMGP (per standard deviation [1178nM] increase) was associated with lower odds of MAC (odds ratio [OR] 0.73; 95% confidence interval [CI] 0.55-0.97) in models adjusted for traditional CVD risk factors, C-reactive protein, and kidney function. Among persons with diabetes (n=221), higher ucMGP was associated with higher odds of MAC (OR 1.89; 95% CI 1.29-2.78). Results were qualitatively similar for the association of ucMGP with AS although not statistically significant.
CONCLUSIONS: Among outpatients with stable CVD, higher ucMGP is associated with lower odds of MAC in persons without diabetes, and higher odds of MAC in persons with diabetes. Future studies should determine whether ucMGP levels are associated with CVD events, and whether such associations differ by diabetes status. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015492      PMCID: PMC2862076          DOI: 10.1016/j.atherosclerosis.2009.11.023

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

2.  Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography.

Authors:  T Skjaerpe; L Hegrenaes; L Hatle
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

3.  Medial arterial calcification and its association with mortality and complications of diabetes.

Authors:  J E Everhart; D J Pettitt; W C Knowler; F A Rose; P H Bennett
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

4.  Decreased insulin production and increased insulin sensitivity in the klotho mutant mouse, a novel animal model for human aging.

Authors:  T Utsugi; T Ohno; Y Ohyama; T Uchiyama; Y Saito; Y Matsumura; H Aizawa; H Itoh; M Kurabayashi; S Kawazu; S Tomono; Y Oka; T Suga; M Kuro-o; Y Nabeshima; R Nagai
Journal:  Metabolism       Date:  2000-09       Impact factor: 8.694

5.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

6.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

7.  Mitral annular calcification: clinical and echocardiographic features.

Authors:  R S Meltzer; R P Martin; B S Robbins; R L Popp
Journal:  Acta Cardiol       Date:  1980       Impact factor: 1.718

8.  Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study.

Authors:  Caroline S Fox; Ramachandran S Vasan; Helen Parise; Daniel Levy; Christopher J O'Donnell; Ralph B D'Agostino; Emelia J Benjamin
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

9.  Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells.

Authors:  Amina F Zebboudj; Victoria Shin; Kristina Boström
Journal:  J Cell Biochem       Date:  2003-11-01       Impact factor: 4.429

10.  Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins.

Authors:  Monzur Murshed; Thorsten Schinke; Marc D McKee; Gerard Karsenty
Journal:  J Cell Biol       Date:  2004-06-07       Impact factor: 10.539

View more
  10 in total

1.  The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Authors:  Benjamin D Parker; Leon J Schurgers; Vincent M Brandenburg; Robert H Christenson; Cees Vermeer; Markus Ketteler; Michael G Shlipak; Mary A Whooley; Joachim H Ix
Journal:  Ann Intern Med       Date:  2010-05-18       Impact factor: 25.391

Review 2.  The role of vitamin K in soft-tissue calcification.

Authors:  Elke Theuwissen; Egbert Smit; Cees Vermeer
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 3.  Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Authors:  M Kyla Shea; Rachel M Holden
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 4.  Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification: a review.

Authors:  Margueritta S El Asmar; Joseph J Naoum; Elias J Arbid
Journal:  Oman Med J       Date:  2014-05

5.  Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.

Authors:  Sophie Liabeuf; Olivier Bourron; Bourron Olivier; Cees Vemeer; Elke Theuwissen; Elke Magdeleyns; Carole Elodie Aubert; Michel Brazier; Romuald Mentaverri; Agnes Hartemann; Ziad A Massy
Journal:  Cardiovasc Diabetol       Date:  2014-04-24       Impact factor: 9.951

6.  Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms.

Authors:  Francesca Romana Ponziani; Maurizio Pompili; Enrico Di Stasio; Maria Assunta Zocco; Antonio Gasbarrini; Roberto Flore
Journal:  World J Gastroenterol       Date:  2017-02-21       Impact factor: 5.742

Review 7.  Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.

Authors:  Stefanos Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

Review 8.  Vitamin K2-a neglected player in cardiovascular health: a narrative review.

Authors:  Essa Hariri; Nicholas Kassis; Jean-Pierre Iskandar; Leon J Schurgers; Anas Saad; Omar Abdelfattah; Agam Bansal; Toshiaki Isogai; Serge C Harb; Samir Kapadia
Journal:  Open Heart       Date:  2021-11

9.  Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.

Authors:  Geertje W Dalmeijer; Yvonne T van der Schouw; Elke J Magdeleyns; Cees Vermeer; W M Monique Verschuren; Jolanda M A Boer; Joline W J Beulens
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

Review 10.  Is Matrix Gla Protein Associated with Vascular Calcification? A Systematic Review.

Authors:  Hilary Barrett; Mary O'Keeffe; Eamon Kavanagh; Michael Walsh; Eibhlís M O'Connor
Journal:  Nutrients       Date:  2018-03-27       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.